Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dihydrophaseic acid 3'-O-b-D-glucopyranoside (D3G) can increase the proliferation and differentiation of osteoblast cells and enhance bone formation, suggests that D3G may be a good candidate for the treatment of osteoporosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 3,170.00 | |
50 mg | 10-14 weeks | $ 4,180.00 | |
100 mg | 10-14 weeks | $ 5,800.00 |
Description | Dihydrophaseic acid 3'-O-b-D-glucopyranoside (D3G) can increase the proliferation and differentiation of osteoblast cells and enhance bone formation, suggests that D3G may be a good candidate for the treatment of osteoporosis. |
Source |
Molecular Weight | 282.33 |
Formula | C15H22O5 |
CAS No. | 41756-77-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dihydrophaseic acid 41756-77-8 Others inhibitor inhibit